Skip to content
10-Q

Quarterly Report

Verona Pharma plc

0001657312-24-000014

← back to feed
Filed
May 10, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 2, 2024 648.65M sh
Long Term Debt Q1 2024 · Mar 31, 2024 $48.55M
Long Term Debt Q1 2024 · Dec 31, 2023 $48.37M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $254.88M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $271.77M
Current Liabilities Q1 2024 · Mar 31, 2024 $14.77M
Current Liabilities Q1 2024 · Dec 31, 2023 $8.69M
Total Liabilities Q1 2024 · Mar 31, 2024 $64.92M
Total Liabilities Q1 2024 · Dec 31, 2023 $58.84M
Current Assets Q1 2024 · Mar 31, 2024 $271.84M
Current Assets Q1 2024 · Dec 31, 2023 $289.71M
Total Assets Q1 2024 · Mar 31, 2024 $289.91M
Total Assets Q1 2024 · Dec 31, 2023 $308.12M
Shares Diluted Q1 2024 · Mar 31, 2023 621.45M sh
Capex Q1 2024 · Mar 31, 2023 $0
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$5.78M
Stockholders Equity Q1 2024 · Mar 31, 2023 $276.75M
Stockholders Equity Q1 2024 · Dec 31, 2022 $230.47M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.03
Eps Basic Q1 2024 · Mar 31, 2023 −$0.03
Sga Expense Q1 2024 · Mar 31, 2023 $9.59M
Net Income Q1 2024 · Mar 31, 2023 −$16.74M
Operating Income Q1 2024 · Mar 31, 2023 −$22.2M